| 2021-03-04 |
详情>>
股本变动：
变动后总股本10934.46万股
|
| 2021-03-04 |
详情>>
业绩披露：
2020年年报每股收益-0.89美元,归母净利润-9238.3万美元,同比去年增长-40.42%
|
| 2021-02-02 |
股东大会：
将于2021-03-08召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to approve the issuance of shares of common stock, par value $0.0001 per share, of NantKwest (the “NantKwest common stock”) to security holders of ImmunityBio, Inc. (“ImmunityBio”) as contemplated by the Agreement and Plan of Merger, dated as of December 21, 2020 (the “merger agreement”), by and among NantKwest, Nectarine Merger Sub, Inc., a wholly owned subsidiary of NantKwest (“Merger Sub”), and ImmunityBio, attached as Annex A to this joint proxy and consent solicitation statement/prospectus (the “stock issuance proposal”).
2.To consider and vote on a proposal to approve the merger contemplated by the merger agreement (the “merger proposal”).
3.To approve the adjournment of the NantKwest special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the stock issuance proposal or the merger proposal (the “adjournment proposal”).
|
| 2020-12-24 |
温馨提示：
美股圣诞休市通知，美股24日（周四）提前三小时休市，12月25日（周五）休市一天。
|
| 2020-11-09 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.59美元,归母净利润-6025.1万美元,同比去年增长-20.15%
|
| 2020-08-07 |
详情>>
业绩披露：
2020年中报每股收益-0.39美元,归母净利润-3847.5万美元,同比去年增长-11.31%
|
| 2020-05-28 |
复牌提示：
2020-05-27 12:05:43 停牌，复牌日期 2020-05-27 12:10:43
|
| 2020-05-11 |
详情>>
业绩披露：
2020年一季报每股收益-0.19美元,归母净利润-1838.3万美元,同比去年增长-2.78%
|
| 2020-04-24 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors from the nominees named in the accompanying proxy statement to serve until our 2021 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2.To approve an amendment to the Company’s 2015 Equity Incentive Plan (as Amended and Restated June 6, 2019) (the “2015 Equity Incentive Plan”) to increase the number of shares of common stock reserved for issuance thereunder by 3,000,000 shares.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
4.To transact other business that may properly come before the annual meeting.
|
| 2020-03-25 |
详情>>
业绩披露：
2019年年报每股收益-0.7美元,归母净利润-6578.9万美元,同比去年增长31.63%
|
| 2020-03-25 |
详情>>
业绩披露：
2017年年报每股收益-1.2美元,归母净利润-9642.3万美元,同比去年增长20.19%
|
| 2019-11-05 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-0.54美元,归母净利润-5014.8万美元,同比去年增长36.43%
|
| 2019-11-05 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-1美元,归母净利润-7888.6万美元,同比去年增长-9.66%
|
| 2019-08-06 |
详情>>
业绩披露：
2019年中报每股收益-0.38美元,归母净利润-3456.7万美元,同比去年增长37.44%
|
| 2019-05-08 |
详情>>
业绩披露：
2019年一季报每股收益-0.22美元,归母净利润-1788.5万美元,同比去年增长35.01%
|
| 2019-04-26 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- (1) To elect six (6) directors from the nominees named in the accompanying proxy statement to serve until our 2020 annual meeting of stockholders and until their respective successors are duly elected and qualified.
(2) To approve an amendment to the Company’s 2015 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 3,000,000 shares.
(3) To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
(4) To transact other business that may properly come before the annual meeting.
|
| 2019-03-13 |
详情>>
业绩披露：
2018年年报每股收益-1.22美元,归母净利润-9622.6万美元,同比去年增长0.20%
|
| 2018-08-23 |
详情>>
内部人交易：
GORLIN STEVE共交易3笔
|
| 2018-04-24 |
股东大会：
将于2018-06-07召开股东大会
会议内容 ▼▲
- (1)To elect six (6) directors from the nominees named in the accompanying proxy statement to serve until our 2019 annual meeting of stockholders and until their respective successors are duly elected and qualified.
(2)To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
(3)To transact other business that may properly come before the annual meeting.
|
| 2017-04-28 |
股东大会：
将于2017-06-09召开股东大会
会议内容 ▼▲
- (1) To elect seven (7) directors from the nominees named in the accompanying proxy statement to serve until our 2018 annual meeting of stockholders and until their respective successors are duly elected and qualified.
(2) To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017.
(3) To transact other business that may properly come before the annual meeting.
|
| 2016-04-27 |
股东大会：
将于2016-06-15召开股东大会
会议内容 ▼▲
- 1. To elect seven (7) directors from the nominees named in the accompanying proxy statement to serve until our 2017 annual meeting of stockholders and until their respective successors are duly elected and qualified.
2. To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2016.
3. To transact other business that may properly come before the annual meeting.
|